Abstract
Intravesical therapy of non-muscle invasive bladder tumors has a long tradition. With regard to low grade tumors prevention of tumor recurrence remains the main endpoint, whereas in high grade tumors prevention of tumor progression is the main aim of intravesical treatment. The following article critically discusses these aspects of non-muscle invasive bladder tumors.
MeSH terms
-
Administration, Intravesical
-
Antineoplastic Agents / therapeutic use*
-
BCG Vaccine / therapeutic use*
-
Carcinoma, Transitional Cell / drug therapy*
-
Carcinoma, Transitional Cell / pathology
-
Carcinoma, Transitional Cell / surgery
-
Combined Modality Therapy
-
Cystectomy
-
Cystoscopy
-
Disease Progression
-
Humans
-
Neoplasm Grading
-
Neoplasm Invasiveness
-
Neoplasm Recurrence, Local / pathology
-
Neoplasm Recurrence, Local / prevention & control
-
Urinary Bladder Neoplasms / drug therapy*
-
Urinary Bladder Neoplasms / pathology
-
Urinary Bladder Neoplasms / surgery
Substances
-
Antineoplastic Agents
-
BCG Vaccine